Abstract.
Objective:
Sivelestat sodium hydrate (sivelestat) is a specific synthetic inhibitor of neutrophil elastase (NE). Various studies suggest that sivelestat treatment reduces inflammation. In this study, we tested the hypothesis that sivelestat acts as an inhibitor of inflammatory mediators and prevents nuclear factor-kB (NF-kB) activation.
Methods:
In the presence and absence of sivelestat, the mouse macrophage cell line RAW 264.7 was stimulated with lipopolysaccharide (LPS) and the levels of inflammatory mediators (TNF-α, IL-6 and high mobility group box 1 (HMGB1)) and nitrite in the cell supernatant were measured, along with inducible nitric oxide synthase (iNOS) expression.
Results:
While LPS administration increased the secretion of inflammatory mediators and nitric oxide (NO), sivelestat decreased the secretion of these mediators. Cell signaling studies demonstrated that sivelestat decreased NF-kB activation by inhibiting IkB phosphorylation.
Conclusion:
Sivelestat may inhibit the various inflammatory mediators through NF-kB inhibition.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 14 June 2008; returned for revision 11 July 2008; received from final revision 4 September 2008; accepted by H. Katori 9 September 2008
Rights and permissions
About this article
Cite this article
Hagiwara, S., Iwasaka, H., Hidaka, S. et al. Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB. Inflamm. Res. 58, 198–203 (2009). https://doi.org/10.1007/s00011-008-8131-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-008-8131-5